Aline Hajj, Professor at the Faculty of Pharmacy, has been awarded prestigious international funding for a research project conducted in collaboration with Université Paris Cité on the neurotoxic effects of chemotherapy.
Congratulations to Aline Hajj, Associate Professor at the Faculty of Pharmacy at Université Laval and member of the QPRN, who has just been awarded joint international funding through the Samuel-De Champlain Program – Research Stream, for a project entitled “Chemotherapy-Induced Neurotoxicity: Preclinical, Clinical, and Genetic Approaches.” This research project is conducted in collaboration with Bruno Mégarbane, Professor at Université Paris Cité in France.
The Samuel-De Champlain Program actively supports strategic partnerships between Quebec and France, while promoting the integration of universities into major international research networks. Other projects funded through this program can be found HERE.
